Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis

This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Respir J
Main Authors: Kreuter, Michael, Lederer, David J., Cottin, Vincent, Kahn, Nicolas, Ley, Brett, Vancheri, Carlo, Weycker, Derek, Atwood, Mark, Kirchgaessler, Klaus-Uwe, Ryerson, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado: European Respiratory Society 2019
Assuntos:
Agora
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6906546/
https://ncbi.nlm.nih.gov/pubmed/31537696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01188-2019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares